These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3672933)

  • 1. Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.
    Dietzschold B; Tollis M; Lafon M; Wunner WH; Koprowski H
    Virology; 1987 Nov; 161(1):29-36. PubMed ID: 3672933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H; Coulon P; Lafay F; Flamand A
    Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of human monoclonal antibodies to rabies.
    Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
    Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.
    Besselaar TG; Blackburn NK
    Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
    Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
    J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9.
    Irie T; Kawai A
    J Gen Virol; 2002 Dec; 83(Pt 12):3045-3053. PubMed ID: 12466481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
    Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
    Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
    J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses.
    Lodmell DL; Ewalt LC
    J Virol; 1987 Oct; 61(10):3314-8. PubMed ID: 3625841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies.
    Luo TR; Minamoto N; Hishida M; Yamamoto K; Fujise T; Hiraga S; Ito N; Sugiyama M; Kinjo T
    Microbiol Immunol; 1998; 42(3):187-93. PubMed ID: 9570284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues.
    Warner C; Fekadu M; Whitfield S; Shaddock J
    J Virol Methods; 1999 Jan; 77(1):69-74. PubMed ID: 10029326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of monoclonal antibodies specific for the internal proteins N and NS of rabies virus.
    Lafon M; Lafage M
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3113-23. PubMed ID: 2447223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies.
    Muhamuda K; Madhusudana SN; Ravi V
    Hum Vaccin; 2007; 3(5):192-5. PubMed ID: 17637573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.
    Dietzschold B; Kao M; Zheng YM; Chen ZY; Maul G; Fu ZF; Rupprecht CE; Koprowski H
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7252-6. PubMed ID: 1496020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of rabies virus neutralization.
    Flamand A; Raux H; Gaudin Y; Ruigrok RW
    Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
    Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
    Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
    Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E.
    Butrapet S; Kimura-Kuroda J; Zhou DS; Yasui K
    Am J Trop Med Hyg; 1998 Apr; 58(4):389-98. PubMed ID: 9574781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.